PubMed HealthSearch

PubMed · 3209174

Surgery for mitral prolapse.

Abstract

Mitral valve prolapse is an increasingly common etiology among patients presenting for mitral valve surgery. From 1985 through 1987, a total of 457 patients underwent surgery for pure mitral regurgitation. Of these, 304 (67%) had underlying mitral prolapse, 57 (12%) had rheumatic valvulitis, 36 (8%) had underlying ischemic disease, and 22 (5%) had bacterial endocarditis. The anatomic disturbance in the patients with prolapse was chordal rupture in 189 (62%), chordal elongation in 69 (23%), and isolated annular dilatation in 46 (15%). Valvuloplasty techniques were used in 294 patients (64%) overall. Among those with mitral prolapse, 208 patients (68%) underwent reconstructive procedures. Operative mortality for the entire group was 7% and for the valvuloplasty group it was 4%. We conclude that 1. in our patient population mitral prolapse is the most frequent etiology among patients requiring surgery for mitral regurgitation; 2. valvuloplasty techniques are applicable in the majority of these patients; 3. valvuloplasty can be performed with low operative mortality. Over the long term, available results indicate good clinical status and low rates of reoperation and thromboembolic events for patients who have undergone mitral valvuloplasty.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A M Chavez, D M Cosgrove. 1988. Surgery for mitral prolapse.. https://pubmed.ncbi.nlm.nih.gov/3209174/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

[Radiotherapy alone in early stages of low malignancy non-Hodgkin lymphomas].

About 25% of patients with low grade Non-Hodgkin's Lymphomas (NHL) of the B-cell type present in an early stage. They are candidates for radiotherapy alone. Thereby a complete remission can be achieved in the majority of stage I and II patients with centroblastic-centrocytic (cb-cc), centrocytic (cc) and immunocytic (ic) NHL--at least in cb-cc also a relapse-free survival of 50-60%. Standardization of the radiotherapeutic technique is essential to reduce the risk of recurrence. Retrospective analyses of radiotherapeutic studies from the literature are limited by the lack of homogenous irradiation techniques. Relapses occur inside as well outside of radiotherapy ports. It is the aim of current studies to optimize the radiotherapeutic approach with curative intent.

Follow-Up Studies

[New therapeutic possibilities in pulmonary emphysema. Conservative therapy--surgical lung volume reduction--lung transplantation].

The spectrum of therapeutic possibilities in pulmonary emphysema has recently been expanded by surgical lung volume reduction. Improvements in surgical technique have now lowered the mortality rate of the procedure to less than 5%, thus providing a chance of prolonging survival and improving the quality of life of severely ill patients in need of oxygen. To date, experience has been gained with this procedure in several thousands of patients in the U.S.A. and Europe, some groups of patients have now been followed up for about three years. The procedure is not recommended for use in patients with genetically determined alpha 1-antitrypsin deficiency. Surgical bullectomy is practiced when individual bullae affect more than 50% of a lung. In special cases, the possibility of lung transplantation should also be considered. In addition to the invasive approaches, survival, but in particular quality of life, can also be improved by conservative procedures. These include medical anti-obstructive treatment, the early use of antibiotics in the case of infections, but also physiotherapeutic measures such as pursed-lip breathing and exercises to strengthen diaphragma. Palliative measures in advanced stages are long-term oxygen therapy and in special cases non-invasive self-ventilation.

Follow-Up Studies